Remidio
PrivateLast Round
Grant
Jun 10, 2026
Est. Valuation
$67.5M
Total Funding Raised
$22.04M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Remidio operates in Healthcare & Life Sciences and is based in Bangalore Urban. Its latest recorded funding round was a Grant round in June 2026.
Remidio is a medical technology company that develops and manufactures AI-powered portable ophthalmic imaging devices designed to help diagnose eye diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remidio Comparables
Compare Remidio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Forus Health | 90% | |
| Phelcom Technologies | 87% | |
| Oivi | 83% |
For institutional investors. Book with your work email.
Remidio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 10, 2026 | ||||
| Corporate Funding | Feb 19, 2023 | ||||
| VC Round | Mar 31, 2022 | ||||
| Grant | Nov 18, 2020 | ||||
| VC Round | May 28, 2018 | ||||
Series B | Jan 15, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Remidio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IKP Knowledge Park | Seed |
| MedTech Innovator | Grant |
| Gates Foundation | Grant |
| Karnataka Information Technology Venture Fund | VC Round |
| Boundary Holding | VC Round |
| Cipher-Plexus Capital Advisors | Series B, Angel |
| Wellcome Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 66% MoM.
- Apr 1, 2026
Oculomics expands screening from eye to systemic diseases.
For institutional investors. Book with your work email.
Remidio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Remidio's valuation, stock price, and market status.
Is Remidio a public or private company?
Remidio is a private company.
What is the current stock price of Remidio?
Remidio is a private company, so its shares have no public market price. Caplight tracks Remidio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Remidio worth (valuation)?
Remidio's valuation is estimated at $67.5M based on funding round data.
Can I buy Remidio stock?
Remidio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Remidio's last funding round?
Remidio's most recent funding round was Grant on June 10, 2026.
Who are the main investors in Remidio?
Key investors in Remidio include Gates Foundation, Boundary Holding, Cipher-Plexus Capital Advisors, Wellcome Trust.
Will Remidio IPO soon?
No public IPO plans have been announced for Remidio.
How can I track Remidio secondary market activity?
Caplight tracks bids, offers, and trades in Remidio's shares on secondary markets.